Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies Find out more

Contact information


bella.turner@ndorms.ox.ac.uk

Anabella Turner

BSc MSc PgCert

Clinical Trial Manager

Clinical trial manager with a passion for improving healthcare and patient pathways through clinical research

I joined the Experimental Medicine and Rheumatology (EMR) group within NDORMS in August 2024 as the Clinical Trial Manager for LEADER, a CTIMP trial analysing the clinical and cost effectiveness of glucocorticoid bridging therapy for patients receiving disease-modifying drugs for Rheumatoid Arthritis.

Prior to working at NDORMS, I worked in the NHS in both patient-facing and administrative research roles as an oncology Trial Coordinator, Research Practitioner and early phase Senior Trial Coordinator. During the pandemic, I seconded as the lead Trial Coordinator for the Oxford/AstraZeneca COVID-19 vaccine study. 

I have a BSc in Physiological Science from the University of Bristol and an MSc in Musculoskeletal Science from University College London. Alongside my Senior Trial Coordinator role, I completed a PgCert in Leading Clinical Research Delivery, focussing on research policy, practice and governance.